New Brain Cancer Immunotherapy Shows Promise in Human Trial – Most Patients Saw No Tumor Growth For 3 Years
[ad_1] A landmark human trial testing a vaccine that is designed to help the immune system attack brain tumors has shown promising results, and Phase 2 of the trial is now being planned. According to a Nature In an article published by the researchers leading the trial, the vaccine was safe for all patients and…









